CA2294569A1 - Proteines secretees et polynucleotides codant ces proteines - Google Patents

Proteines secretees et polynucleotides codant ces proteines Download PDF

Info

Publication number
CA2294569A1
CA2294569A1 CA002294569A CA2294569A CA2294569A1 CA 2294569 A1 CA2294569 A1 CA 2294569A1 CA 002294569 A CA002294569 A CA 002294569A CA 2294569 A CA2294569 A CA 2294569A CA 2294569 A1 CA2294569 A1 CA 2294569A1
Authority
CA
Canada
Prior art keywords
seq
polynucleotide
amino acid
protein
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002294569A
Other languages
English (en)
Inventor
Kenneth Jacobs
John M. Mccoy
Edward R. Lavallie
Lisa A. Racie
Maurice Treacy
Vikki Spaulding
Michael J. Agostino
Steven H. Howes
Kim Fechtel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2294569A1 publication Critical patent/CA2294569A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cette invention se rapporte à de nouveaux polynucléotides ainsi qu'aux protéines codées par ceux-ci.
CA002294569A 1997-06-19 1998-06-18 Proteines secretees et polynucleotides codant ces proteines Abandoned CA2294569A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87871597A 1997-06-19 1997-06-19
US08/878,715 1997-06-19
US9858898A 1998-06-17 1998-06-17
US09/098,588 1998-06-17
PCT/US1998/012516 WO1998057976A1 (fr) 1997-06-19 1998-06-18 Proteines secretees et polynucleotides codant ces proteines

Publications (1)

Publication Number Publication Date
CA2294569A1 true CA2294569A1 (fr) 1998-12-23

Family

ID=26794899

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002294569A Abandoned CA2294569A1 (fr) 1997-06-19 1998-06-18 Proteines secretees et polynucleotides codant ces proteines

Country Status (5)

Country Link
EP (1) EP1003770A4 (fr)
JP (1) JP2002513294A (fr)
AU (1) AU7970498A (fr)
CA (1) CA2294569A1 (fr)
WO (1) WO1998057976A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516734A (ja) * 1999-12-01 2003-05-20 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 癌関連抗原およびその使用
JP5504562B2 (ja) * 2006-12-20 2014-05-28 東レ株式会社 癌の検出方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
EP0706563B1 (fr) * 1993-06-29 2004-10-06 Chiron Corporation Un facteur de croissance des keratinocytes (kgf) tronque a activite biologique accrue
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US5708157A (en) * 1996-07-26 1998-01-13 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same

Also Published As

Publication number Publication date
JP2002513294A (ja) 2002-05-08
WO1998057976A1 (fr) 1998-12-23
EP1003770A1 (fr) 2000-05-31
EP1003770A4 (fr) 2002-10-30
AU7970498A (en) 1999-01-04

Similar Documents

Publication Publication Date Title
CA2269755A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2283631A1 (fr) Proteines secretees et polynucleotides les codant
CA2285554A1 (fr) Proteines secretees et polynucleotides les codant
CA2288343A1 (fr) Proteines secretees et polynucleotides les codant
CA2283195A1 (fr) Proteines secretees et polynucleotides les codant
CA2274732A1 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
CA2306457A1 (fr) Proteines secretees et polynucleotides les codant
CA2286290A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2281059A1 (fr) Proteines secretees et polynucleotides les codant
CA2310214A1 (fr) Proteines secretees et polynucleotides les codant
CA2278770A1 (fr) Proteines secretees et polynucleotides les codant
CA2283193A1 (fr) Proteines secretees et polynucleotides codant ces dernieres
CA2298451A1 (fr) Proteines secretees et polynucleotides les codant
CA2293363A1 (fr) Proteines secretees et polynucleotides les codant
CA2294569A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2284109A1 (fr) Proteines secretees et polynucleotides les codant
CA2322732A1 (fr) Proteines secretees et polynucleotides les codant
CA2273845A1 (fr) Proteines secretees et polynucleotides les codant
CA2276085A1 (fr) Proteines secretees et polynucleotides les codant
CA2278153A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2278104A1 (fr) Proteines secretees et polynucleotides les codant
CA2291485A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2309782A1 (fr) Proteines secretees et polynucleotides les codant
CA2281015A1 (fr) Proteines secretees et polynucleotides codant pour celles-ci
CA2324504A1 (fr) Proteines secretees et polynucleotides les codant

Legal Events

Date Code Title Description
FZDE Dead